Triclosan
This article was originally published in The Rose Sheet
Executive Summary
Consumers should refrain from using soap and other products containing triclosan and other biocides at home, according to the Federal Institute for Risk Assessment, a new scientific body of the Federal Republic of Germany. Noting consumer products contain only low doses of triclosan insufficient to kill bacterial pathogens, FIRA adds, "When it comes to everyday life, soap and water or conventional cleansing products are quite capable of achieving the same effect." The institute expressed concern over the risk of increasing resistance of microorganisms to the ingredient, and concluded products containing triclosan should only be used in clinics and doctors' offices. Antibacterial resistance associated with triclosan use has been a topic of increasing interest in the U.S. In October, FDA's Nonprescription Drugs Advisory Committee unanimously agreed that makers of non-alcohol-based antimicrobials should be required to demonstrate products' clinical benefit prior to sale (1"The Rose Sheet" Oct. 24, 2005, p. 9)...
You may also be interested in...
Non-Alcohol Antiseptic Hand Products Should Prove Efficacy – NDAC
Marketers of non-alcohol-based consumer antiseptic products should be required to prove their products provide clinical benefit prior to sale, an FDA advisory panel unanimously agreed Oct. 20
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.